-
Molecular Profiling, Treatment (Tx) Patterns, and Healthcare Resource Utilization (HCRU) in United States Patients with Unresectable Locally Advanced/Metastatic Biliary Tract Cancer
Mar 10, 2025, 14:00 PM -
Frequently Asked Questions (FAQs): What Are the Risks and Mitigation Strategies in Using Gen-AI in HEOR?
Mar 10, 2025, 14:00 PM -
Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs
Mar 10, 2025, 14:00 PM -
Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies
Mar 10, 2025, 14:00 PM -
How to Mitigate "Carer QALY Trap" when Including Caregiver QOL in Cost-Effectiveness Analysis: A Model Simulation Using Lecanemab in Japanese Patients with Alzheimer's Disease
Mar 10, 2025, 14:00 PM -
The Economic Benefit of Biosimilars in North America: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Unmet Needs and Evidence Gaps Among Patients with DLBCL treated with CAR-T Therapy: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Assessing Real-World Dosing Patterns for Vesicular Monoamine Transporter-2 Inhibitors (VMAT2i), Valbenazine and Deutetrabenazine, Among Patients with Tardive Dyskinesia (TD) in a Nationwide US Claims Database
Mar 10, 2025, 14:00 PM -
A Comparative Assessment of ICER-Sponsored Versus Pharma-Sponsored Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Real-World (rw) Early Clinical Endpoints for Patients with Resectable Non-Small Cell Lung Cancer (NSCLC): A Database Evaluation Study
Mar 10, 2025, 14:00 PM -
Microbiology Testing and Oral Antibiotic Treatment Among CKD Patients With Urinary Tract Infections: Real-World Evidence From a US EMR Network
Mar 10, 2025, 14:00 PM -
Effectiveness of Early Remdesivir Initiation in Patients with Immunocompromising Conditions Hospitalized with COVID-19 by Variant Era, Level of Immunocompromise, and Age
Mar 10, 2025, 14:00 PM -
Health Disparities in In-Hospital Mortality Related to Bloodstream Infections in the US: A Retrospective Cohort Study
Mar 10, 2025, 14:00 PM -
Survival Outcomes of Stage IV Endometrial Cancer Patients with Lung Metastasis: A SEER-Based Cohort Study
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab in 1L Recurrent/Metastatic Head and Neck Squamous Cell Cancer (R/M HNSCC) in Brazil
Mar 10, 2025, 14:00 PM -
Inequities in Access to Oncology Drugs in Brazil - the Case of Public and Private Healthcare Systems
Mar 10, 2025, 14:00 PM -
Correlation and Predictors of EORTC QLQ-C30 GHS-QoL and EQ-5D VAS in Patients With Advanced NSCLC
Mar 10, 2025, 14:00 PM -
Balancing Baseline Characteristics With SMOTE and Propensity Score Weighting in a Comparative Study of PASCAL Transcatheter Valve Repair and Medical Therapy for Degenerative Mitral Regurgitation
Mar 10, 2025, 14:00 PM -
Geographic Inequities in Bariatric Surgery Access in Southern Chile: The Case of the Chilean Bundled Payment PAD
Mar 10, 2025, 14:00 PM -
A Model-Based Cost-Effectiveness Analysis of Anamorelin and Olanzapine in NSCLC Cachexia Treatment in Japan
Mar 10, 2025, 14:00 PM
